CRIS Current Research Information System
IRIS è la soluzione IT che facilita la raccolta e la gestione dei dati relativi alle attività e ai prodotti della ricerca. Fornisce a ricercatori, amministratori e valutatori gli strumenti per monitorare i risultati della ricerca, aumentarne la visibilità e allocare in modo efficace le risorse disponibili.
ItalianoCHIARINI, FRANCESCA
Pubblicazioni
Risultati 1 - 20 di 32 (tempo di esecuzione: 0.002 secondi).
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
|---|---|---|---|---|---|---|---|
| 1 | A role of PI-PLCb1 in G1/S transition in human erythroleukemia k562 cells | Alessandro Poli; Irene Faenza; Alessandro Matteucci; Francesca Chiarini; Lucio Cocco | 2012 | 4.03 Poster | - | ||
| 2 | Activity of the novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235, against T-cell acute lymphoblastic leukemia. | F. Chiarini; C. Grimaldi; F. Ricci; P. L. Tazzari; C.Evangelisti; A. Ognibene; M.Battistelli; E. ...Falcieri; F. Melchionda; A. Pession; P. Pagliaro; J.A. McCubrey; A.M. Martelli. | 2010 | CANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 3 | Alteration of Akt activity increases chemotherapeutic drug and hormonal resistance in breast cancer yet confers an achilles heel by sensitization to targeted therapy | McCubrey J.A.; Sokolosky M.L.; Lehmann B.D.; Taylor J.R.; Navolanic P.M.; Chappell W.H.; Abrams S....L.; Stadelman K.M.; Wong E.W.; Misaghian N.; Horn S.; Bäsecke J.; Libra M.; Stivala F.; Ligresti G.; Tafuri A.; Milella M.; Zarzycki M.; Dzugaj A.; Chiarini F.; Evangelisti C.; Martelli A.M.; Terrian D.M.; Franklin R.A.; Steelman L.S. | 2008 | Elsevier Ltd. | 2.01 Capitolo / saggio in libro | - | |
| 4 | AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications. | Grimaldi C.; Chiarini F.; Tabellini G.; Ricci F.; Tazzari P.L.; Battistelli M.; Falcieri E.; Bort...ul R.; Melchionda F.; Iacobucci I.; Pagliaro P.; Martinelli G.; Pession A.; Barata J.T.; McCubrey J.A.; Martelli A.M. | 2012 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 5 | ASSESSMENT OF THE EFFECT OF SPHINGOSINE KINASE INHIBITORS ON APOPTOSIS, UNFOLDED PROTEIN RESPONSE AND AUTOPHAGY OF T-ACUTE LYMPHOBLASTIC LEUKEMIA CELLS: INDICATIONS FOR NOVEL THERAPEUTICS | Evangelisti, C; Evangelisti, C; Teti, G; Falconi, M; Cappellini, A; Chiarini, F; Buontempo, F; Br...essanin, D; Lonetti, A; Spartà, A; Bittman, R; Pyne, S; Pyne, N; Martelli, Am | 2014 | HAEMATOLOGICA | 4.02 Riassunto (Abstract) | - | |
| 6 | A COMBINATION OF BORTEZOMIB WITH CX-4945, A CASEIN KINASE 2 (CK2) INHIBITOR, HAS SYNERGISTIC CYTOTOXIC EFFECTS IN ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) CELL LINES | Buontempo, Francesca; Orsini, E; Cappellini, Alessandra; Lonetti, Annalisa; Evangelisti, C; Chiar...ini, Francesca; Spartà, Am; Bressanin, D; Evangelisti, C; Martelli, Am | 2014 | HAEMATOLOGICA | 4.02 Riassunto (Abstract) | - | |
| 7 | Dual inhibition of class IA phoshatidylinositol 3-kinase and mTOR as a new therapeutic option for T-cell acute lymphoblastic leukemia. | F. Chiarini; F. Falà; P. L. Tazzari; F. Ricci; A. Astolfi; A. Pession; P. Pagliaro; J.A. McCubrey...; A.M. Martelli. | 2009 | CANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 8 | Effect of Erythropoietin Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients. | Matilde Y Follo; Sara Mongiorgi; Cristina Clissa; Francesca Chiarini; Stefania Paolini; Michele B...accarani; Giovanni Martinelli; Lucia Manzoli; Alberto M. Martelli; Carlo Finelli; Lucio Cocco | 2009 | BLOOD | 4.01 Contributo in Atti di convegno | - | |
| 9 | Effect of Lenalidomide Treatment on Lipid Signalling Pathways in Low-Risk MDS Patients | Matilde Y Follo; Cristina Clissa; Sara Mongiorgi; Francesca Chiarini; Michele Baccarani; Giovanni... Martinelli; Lucia Manzoli; Alberto M Martelli; Carlo Finelli; Lucio Cocco | 2011 | BLOOD | 4.01 Contributo in Atti di convegno | - | |
| 10 | The Emerging Role of the Phosphatidylinositol 3-Kinase/Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology. | A.M. Martelli; C. Evangelisti; F. Chiarini; C. Grimaldi; J.A. McCubrey. | 2010 | CANCERS | 1.01 Articolo in rivista | ||
| 11 | Erucylphosphohomocholine, the first intravenously applicable alkylphosphocholine, is cytotoxic to acute myelogenous leukemia cells through JNK- and PP2A-dependent mechanisms. | A.M. Martelli; V. Papa; P.L. Tazzari; F. Ricci; C. Evangelisti; F. Chiarini; C. Grimaldi; A. Capp...ellini; G. Martinelli; E. Ottaviani; P. Pagliaro; S. Horn; J. Bäsecke; L.H. Lindner; H. Eibl; J.A. McCubrey. | 2010 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 12 | Inhibition of methyltransferase dot1l sensitizes to sorafenib treatment aml cells irrespective of mll-rearrangements: A novel therapeutic strategy for pediatric aml | Lonetti A.; Indio V.; Laginestra M.A.; Tarantino G.; Chiarini F.; Astolfi A.; Bertuccio S.N.; Mar...telli A.M.; Locatelli F.; Pession A.; Masetti R. | 2020 | CANCERS | 1.01 Articolo in rivista | ||
| 13 | Involvement of nuclear PLC{beta}1 in lamin B1 phosphorylation and G2/M cell cycle progression. | Fiume R; Ramazzotti G; Teti G; Chiarini F; Faenza I; Mazzotti G; Billi AM; Cocco L | 2009 | THE FASEB JOURNAL | 1.01 Articolo in rivista | - | |
| 14 | Preclinical testing of the Akt inhibitor triciribine in T-cell acute lymphoblastic leukemia | Evangelisti C; Ricci F; Tazzari P; Chiarini F; Battistelli M; Falcieri E; Ognibene A; Pagliaro P;... Cocco L; McCubrey JA; Martelli AM | 2011 | JOURNAL OF CELLULAR PHYSIOLOGY | 1.01 Articolo in rivista | - | |
| 15 | Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor (2S)-1-(1H-Indol-3-yl)-3-[5-(3-methyl-2H-indazol-5-yl)pyridin-3-yl]oxypropan2-ami ne (A443654) in T-cell acute lymphoblastic leukemia. | Falà F; Blalock WL; Tazzari PL; Cappellini A; Chiarini F; Martinelli G; Tafuri A; McCubrey JA; Co...cco L; Martelli AM | 2008 | MOLECULAR PHARMACOLOGY | 1.01 Articolo in rivista | - | |
| 16 | Proapoptotic activity and chemosensitizing effect of the novel Akt inhibitor perifosine in acute myelogenous leukemia cells | V. Papa; P.L. Tazzari; F. Chiarini; A. Cappellini; F. Ricci; A.M. Billi; C. Evangelisti; E. Ottav...iani; G. Martinelli; N. Testoni; J.A. McCubrey; A.M. Martelli | 2008 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 17 | Reduction of phosphoinositide-phospholipase C beta1 methylation predicts the responsiveness to azacitidine in high-risk MDS. | Follo MY; Finelli C; Mongiorgi S; Clissa C; Bosi C; Testoni N; Chiarini F; Ramazzotti G; Baccara...ni M; Martelli AM; Manzoli L; Martinelli G; Cocco L | 2009 | PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA | 1.01 Articolo in rivista | - | |
| 18 | Synergistic induction of PI-PLCbeta1 signaling by azacitidine and valproic acid in high-risk myelodysplastic syndromes | Follo MY; Finelli C; Mongiorgi S; Clissa C; Chiarini F; Ramazzotti G; Paolini S; Martinelli G; Ma...rtelli AM; Cocco L | 2011 | LEUKEMIA | 1.01 Articolo in rivista | - | |
| 19 | Synergistic proapoptotic activity of recombinant TRAIL plus the Akt inhibitor perifosine in acute myeloid leukemia cells. | Tazzari P.L.; Tabellini G.; Ricci F.; Papa V.; Bortul R.; Chiarini F.; Evangelisti C.; Martinelli... G.; Bontadini A.; Cocco L.; McCubrey J.A.; Martelli A.M. | 2008 | CANCER RESEARCH | 1.01 Articolo in rivista | - | |
| 20 | Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia. | Evangelisti C.; Ricci F.; Tazzari P.; Tabellini G.; Battistelli M.; Falcieri E.; Chiarini F.; Bor...tul R.; Melchionda F.; Pagliaro P.; Pession A.; McCubrey J.A.; Martelli A.M. | 2011 | LEUKEMIA | 1.01 Articolo in rivista | - |
Dettaglio
CHIARINI, FRANCESCA
DIPARTIMENTO DI SCIENZE BIOMEDICHE E NEUROMOTORIE
Personale esterno ed autonomi
Copyright © 2020